Core Insights - Fangzhou Inc. received the "Excellence Award" at Gilead Sciences' 2025 Multi-Channel Conference, recognizing its innovation in AI-driven Internet healthcare solutions [1][2] - The collaboration between Fangzhou and Gilead focuses on enhancing chronic disease management and improving patient outcomes through digital health solutions [3][6] Company Achievements - Fangzhou's AI technology has significantly advanced chronic disease management, as highlighted by Dr. Xie Fangmin during the conference [2][4] - The company serves 52.8 million registered users and 229,000 physicians, positioning itself as a leader in online chronic disease management in China [8] Strategic Collaborations - Fangzhou and Gilead are working together on disease prevention, treatment, and digital chronic care services, aligning their visions for better health outcomes [3][6] - The launch of Gilead's initiative "Together for Health" aims to enhance patient-centric services, with Fangzhou pledging to contribute to this integrated ecosystem [4][6] Future Directions - Fangzhou plans to leverage its AI technology and chronic disease management services while integrating Gilead's expertise in areas such as HIV and oncology to explore new care models [6]
Fangzhou Wins Gilead ‘Award of Excellence’ for AI-Driven Chronic Disease Management